Stock analysts at Deutsche Bank assumed coverage on shares of athenahealth (NASDAQ:ATHN) in a research note issued on Friday, MarketBeat reports. The brokerage set a “hold” rating and a $145.00 price target on the health services provider’s stock. Deutsche Bank’s price objective suggests a potential upside of 9.97% from the company’s previous close.

Several other brokerages have also recently weighed in on ATHN. Robert W. Baird reaffirmed a “buy” rating and set a $170.00 price target on shares of athenahealth in a research note on Thursday, August 31st. BidaskClub raised shares of athenahealth from a “strong sell” rating to a “sell” rating in a research note on Saturday, December 2nd. Jefferies Group decreased their target price on shares of athenahealth from $135.00 to $120.00 and set a “hold” rating for the company in a research note on Friday, September 15th. KeyCorp reissued a “buy” rating and issued a $170.00 target price on shares of athenahealth in a research note on Sunday, September 17th. Finally, Royal Bank Of Canada began coverage on shares of athenahealth in a research note on Tuesday, September 19th. They issued a “sector perform” rating and a $153.00 target price for the company. Two investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and eleven have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $143.29.

Shares of athenahealth (NASDAQ ATHN) traded down $3.69 on Friday, hitting $131.86. 328,070 shares of the stock traded hands, compared to its average volume of 573,166. The company has a market cap of $5,420.00, a PE ratio of 113.37, a P/E/G ratio of 5.02 and a beta of 1.57. athenahealth has a one year low of $92.38 and a one year high of $158.66. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.35.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.06. The company had revenue of $304.60 million during the quarter, compared to analysts’ expectations of $310.52 million. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The business’s quarterly revenue was up 10.1% on a year-over-year basis. During the same period last year, the business earned $0.60 EPS. equities research analysts forecast that athenahealth will post 1.2 EPS for the current year.

In other news, CEO Jonathan Bush sold 4,000 shares of athenahealth stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $124.17, for a total transaction of $496,680.00. Following the completion of the sale, the chief executive officer now owns 319,807 shares of the company’s stock, valued at $39,710,435.19. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Brandon H. Hull sold 800 shares of athenahealth stock in a transaction on Friday, December 1st. The stock was sold at an average price of $132.97, for a total value of $106,376.00. The disclosure for this sale can be found here. Insiders have sold 9,283 shares of company stock valued at $1,175,908 in the last three months. Insiders own 3.20% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the company. Turner Investments LLC acquired a new stake in shares of athenahealth during the second quarter worth $105,000. Bessemer Group Inc. raised its stake in athenahealth by 13.7% in the second quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock valued at $132,000 after purchasing an additional 113 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in athenahealth by 7.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after purchasing an additional 84 shares in the last quarter. BNP Paribas Arbitrage SA raised its stake in athenahealth by 123.8% in the second quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock valued at $189,000 after purchasing an additional 744 shares in the last quarter. Finally, ProShare Advisors LLC acquired a new position in athenahealth in the second quarter valued at about $205,000.

ILLEGAL ACTIVITY WARNING: “athenahealth (ATHN) Receives New Coverage from Analysts at Deutsche Bank” was first published by American Banking News and is owned by of American Banking News. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/12/08/athenahealth-athn-receives-new-coverage-from-analysts-at-deutsche-bank.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.